CellWell record HH-565193
Immune-Mediated Colitis Induced by Immune Checkpoint Inhibitors: Pathophysiology, Clinical Management, and the Emerging Role of Fecal Microbiota Transplantation
Zeljka Belosic Halle; Vedran Tomasic; Alen Biscanin; Petra Cacic; Ivona Saric; Sanda Mustapic; Josip Stojic; Kresimir Luetic; Dinko Bekic; Matej Paic; Domagoj Micetic; Irena Krznaric Zrnic; Ivna Olic; Melanija Razov Radas; Iva Skocilic; Marin Golčic; Laura Rados; Jasna Radic; Juraj Prejac; Ivana Mikolasevic
2026
In plain language
This review found corticosteroids remain first-line therapy for immune checkpoint inhibitor-induced colitis, with infliximab and vedolizumab effective in steroid-refractory cases and fecal microbiota transplantation showing promise in refractory disease.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-565193
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.